Franklin Resources
TXMD icon

Franklin Resources’s TherapeuticsMD TXMD Stock Holding History

Franklin Resources’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-131,884
Closed -$6.99M – 1740
2020
Q1 		$6.99M Sell
131,884
-57,787
-30% -$5.73M ﹤0.01% 866
2019
Q4 		$22.9M Sell
189,671
-15,165
-7% -$2.18M 0.01% 729
2019
Q3 		$37.2M Buy
204,836
+528
+0.3% +$74.4K 0.02% 599
2019
Q2 		$26.6M Sell
204,308
-6,768
-3% -$1.21M 0.01% 690
2019
Q1 		$51.4M Buy
211,076
+204
+0.1% +$54K 0.03% 520
2018
Q4 		$40.2M Buy
210,872
+4,720
+2% +$1.15M 0.02% 529
2018
Q3 		$67.6M Sell
206,152
-4,681
-2% -$1.43M 0.03% 465
2018
Q2 		$65.8M Sell
210,833
-381
-0.2% -$116K 0.03% 462
2018
Q1 		$51.4M Sell
211,214
-8,634
-4% -$2.42M 0.03% 524
2017
Q4 		$66.4M Buy
219,848
+12,259
+6% +$3.41M 0.03% 466
2017
Q3 		$54.9M Buy
207,589
+1,088
+0.5% +$315K 0.03% 503
2017
Q2 		$54.4M Sell
206,501
-1,507
-0.7% -$377K 0.03% 508
2017
Q1 		$74.9M Sell
208,008
-17,120
-8% -$5.3M 0.04% 422
2016
Q4 		$64.9M Buy
225,128
+19,625
+10% +$6.08M 0.03% 454
2016
Q3 		$70M Buy
205,503
+6,037
+3% +$2.2M 0.04% 433
2016
Q2 		$84.8M Buy
199,466
+24,874
+14% +$10.3M 0.05% 386
2016
Q1 		$55.9M Buy
174,592
+10,398
+6% +$3.55M 0.03% 507
2015
Q4 		$85.1M Buy
164,194
+26,938
+20% +$9.94M 0.04% 399
2015
Q3 		$40.2M Buy
137,256
+988
+0.7% +$351K 0.02% 637
2015
Q2 		$53.6M Buy
136,268
+3,368
+3% +$1.19M 0.02% 581
2015
Q1 		$40.2M Buy
132,900
+48,060
+57% +$11.7M 0.02% 679
2014
Q4 		$18.9M Buy
84,840
+14,616
+21% +$3.01M 0.01% 890
2014
Q3 		$16.3M Sell
70,224
-2,624
-4% -$661K 0.01% 931
2014
Q2 		$16.1M Hold
72,848
– – 0.01% 936
2014
Q1 		$23M Buy
72,848
+1,162
+2% +$370K 0.01% 822
2013
Q4 		$18.7M Buy
71,686
+2,332
+3% +$511K 0.01% 826
2013
Q3 		$10.2M Buy
69,354
+15,914
+30% +$1.92M 0.01% 970
2013
Q2 		$8.1M Buy
+53,440
New +$7.32M ﹤0.01% 987

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources's TXMD Position: Q2 2020 in Review

Franklin Resources sold out of TherapeuticsMD (TXMD) in Q2 2020, closing a stake of 131,884 shares — an estimated $6.99M sold.

Franklin Resources first reported a position in TXMD in Q2 2013 and held it in 28 quarters. The position peaked at $85.1M in Q4 2015. 149 funds tracked by Wall St. Rank hold TXMD as of Q2 2020.

  • Franklin Resources reported no remaining TherapeuticsMD position as of Q2 2020 after selling out during the quarter.
  • Franklin Resources sold 131,884 TherapeuticsMD shares in Q2 2020, an estimated $6.99M.
  • Franklin Resources first reported a position in TherapeuticsMD in Q2 2013 and held it in 28 quarters.
  • Franklin Resources's TherapeuticsMD position peaked at $85.1M in Q4 2015.
  • 149 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2020.

Based on Franklin Resources's 13F filing for Q2 2020, filed 13 Aug 2020.